ERIKA KANG: Open Payments
NPI 1639568066 · CUMMING, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,116 in 57 payments from 15 companies in 2025. Trend: 2023 $171 · 2024 $705 · 2025 $1,116
Food & beverage: $1,116
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $227 |
| ABBVIE INC. | 12 | $169 |
| Axsome Therapeutics, Inc. | 3 | $135 |
| Otsuka America Pharmaceutical, Inc. | 5 | $132 |
| Lundbeck LLC | 3 | $69 |
| Tris Pharma Inc | 3 | $57 |
| Janssen Pharmaceuticals, Inc | 2 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $46 |
| Neurocrine BioSciences, Inc. | 2 | $45 |
| Alkermes, Inc. | 2 | $40 |
Products named: CAPLYTA, REXULTI, VRAYLAR, Auvelity, Dyanavel XR, TRINTELLIX, INGREZZA, Azstarys.
Industry payments across GA — which companies pay providers there.
